Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tego Science Inc. (191420:KRX), powered by AI.
Tego Science Inc. is currently trading at ₩7,980. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Tego Science Inc. on Alpha Lenz.
Tego Science Inc.'s P/E ratio is -9.4.
“Tego Science Inc. trades at a P/E of -9.4 (undervalued) with modest ROE of -14.0%.”
Ask for details →Tego Science Inc. is a biotechnology company specializing in the development and production of regenerative medicine products. The primary focus of Tego Science Inc. lies in tissue engineering and the advancement of cell therapy treatments, targeting various therapeutic areas that demand innovative solutions for tissue repair and reconstruction. With a portfolio that includes patented technologies and products such as autologous skin cell culture systems, Tego Science Inc. plays a pivotal role in the healthcare sector, particularly impacting areas such as burns, chronic wounds, and plastic surgery. By addressing critical needs in regenerative medicine, Tego Science Inc. not only contributes to improved patient outcomes but also significantly influences advancements within the life sciences industry. Operating out of South Korea, the company’s contributions to medical technology underscore the growing importance and application of regenerative techniques in modern healthcare.
“Tego Science Inc. trades at a P/E of -9.4 (undervalued) with modest ROE of -14.0%.”
Ask for details →Tego Science Inc. (ticker: 191420) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $65.7B.
The current price is ₩7,980 with a P/E ratio of -9.37x and P/B of 1.3x.
ROE is -13.97% and operating margin is -74.48%. Annual revenue is $5.9B.